Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Treatment of early stage cervical and ovarian cancer

Dr Rama Joshi - Foirtis Memorial Research Institute, Gurgaon, India
Treatment of early stage cervical and ovarian cancer ( Dr Rama Joshi - Foirtis Memorial Research Institute, Gurgaon, India )
20 Feb 2020

India's strategy for the prevention of head and neck cancers and lung cancer

Dr Abhishek Shankar - Consultant Oncologist, AIIMS, New Delhi, India
India's strategy for the prevention of head and neck cancers and lung cancer ( Dr Abhishek Shankar - Consultant Oncologist, AIIMS, New Delhi, India )
20 Feb 2020

Treatment of early stage breast cancer

Dr Siddharth Sahni - Apollo Indraprastha Hospital, New Delhi, India
Treatment of early stage breast cancer ( Dr Siddharth Sahni - Apollo Indraprastha Hospital, New Delhi, India )
20 Feb 2020

Choosing wisely with breast cancer in India

Dr Shona Nag - Sahyadri Hospitals, Pune, India
Choosing wisely with breast cancer in India ( Dr Shona Nag - Sahyadri Hospitals, Pune, India )
20 Feb 2020

EV-103: Enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma

Dr Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA
EV-103: Enfortumab vedotin plus pembrolizumab for locally advanced or metastatic urothelial carcinoma ( Dr Jonathan Rosenberg - Memorial Sloan Kettering Cancer Center, New York, USA )
19 Feb 2020

KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC

Dr Julie Graff - Oregon Health & Science University, Portland, USA
KEYNOTE 199 cohorts 4 & 5: Enzalutamide and pembrolizumab for mCRPC ( Dr Julie Graff - Oregon Health & Science University, Portland, USA )
19 Feb 2020

BCG dosing for bladder cancer: Standard frequency schedule correct

Prof Oliver Grimm - Universitätsklinikum Jena, Jena, Germany
BCG dosing for bladder cancer: Standard frequency schedule correct ( Prof Oliver Grimm - Universitätsklinikum Jena, Jena, Germany )
19 Feb 2020

RADVAX: Nivolumab / ipilimumab with SBRT for metastatic renal cell carcinoma

Dr Hans Hammers - UT Southwestern Medical Center, Dallas, USA
RADVAX: Nivolumab / ipilimumab with SBRT for metastatic renal cell carcinoma ( Dr Hans Hammers - UT Southwestern Medical Center, Dallas, USA )
19 Feb 2020

CHAARTED: Luminal B subtype as a biomarker of docetaxel benefit for mHSPC

Dr Anis Hamid - Dana-Farber Cancer Institute, Boston, USA
CHAARTED: Luminal B subtype as a biomarker of docetaxel benefit for mHSPC ( Dr Anis Hamid - Dana-Farber Cancer Institute, Boston, USA )
19 Feb 2020

Choosing wisely: Lung adenocarcinoma

Dr Navneet Singh - Post Graduate Institute of Medical Education & Research, Chandigarh, India
Choosing wisely: Lung adenocarcinoma ( Dr Navneet Singh - Post Graduate Institute of Medical Education & Research, Chandigarh, India )
18 Feb 2020

Integrative molecular characterisation of S/R RCC to reveal determinants of poor prognosis and response to ICIs

Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA
Integrative molecular characterisation of S/R RCC to reveal determinants of poor prognosis and response to ICIs ( Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA )
18 Feb 2020

Cytoreductive nephrectomy for mRCC treated with immune checkpoint inhibitors or targeted therapy

Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA
Cytoreductive nephrectomy for mRCC treated with immune checkpoint inhibitors or targeted therapy ( Dr Ziad Bakouny - Dana-Farber Cancer Institute, Boston, USA )
18 Feb 2020